Karen Dolezal
Physician Assistant · Columbia, SCNPI 1649702267
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 501 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,177 and has fallen 53.7% since, to $1,471 in 2025. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 501 payments — averaging $21.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Amgen$1K
- AstraZeneca$918
- Pfizer$633
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$573
- Merck$518
- plus $5K from 28 others
What the payments were for
- Food & beverage$10,75999%
- Education$1041%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 125 | $2,250 |
| Amgen | 63 | $1,239 |
| AstraZeneca | 38 | $918 |
| Pfizer | 35 | $633 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $573 |
| Merck | 23 | $518 |
| Boston Scientific | 9 | $515 |
| E.r. Squibb & Sons, L.L.C. | 31 | $508 |
| Philips North America LLC | 14 | $384 |
| Boehringer Ingelheim | 19 | $377 |
| Axsome Therapeutics, Inc. | 7 | $340 |
| Esperion Therapeutics, Inc. | 18 | $332 |
| Alnylam Pharmaceuticals Inc. | 15 | $319 |
| Johnson & Johnson | 19 | $283 |
| Scpharmaceuticals Inc. | 14 | $278 |
| Bayer | 9 | $237 |
| Shionogi Inc | 2 | $224 |
| Abbott | 6 | $129 |
| Novo Nordisk | 2 | $123 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $96 |
| Lexicon Pharmaceuticals, Inc. | 5 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $86 |
| Arbor Pharmaceuticals, Inc. | 5 | $74 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $50 |
| Sanofi | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 1 | $28 |
| Cardiva Medical, Inc. | 1 | $26 |
| Impulse Dynamics (USA) Inc. | 1 | $26 |
| Cvrx, Inc. | 1 | $26 |
| Atricure, Inc. | 1 | $26 |
| Edwards Lifesciences | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,863 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 391 | $435,077 |
| Repatha SureclickEvolocumab | 217 | $217,794 |
| XareltoRivaroxaban | 73 | $100,452 |
| EntrestoSacubitril/Valsartan | 82 | $97,636 |
| JardianceEmpagliflozin | 61 | $56,689 |
| FarxigaDapagliflozin Propanediol | 16 | $21,661 |
| BrilintaTicagrelor | 12 | $14,378 |
| Praluent PenAlirocumab | 20 | $13,490 |
| SunosiSolriamfetol Hcl | 16 | $13,402 |
| Clonidine | 57 | $10,660 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 81 | $10,435 |
| Rosuvastatin Calcium | 327 | $6,617 |
| Metoprolol Succinate | 345 | $5,863 |
| VascepaIcosapent Ethyl | 11 | $5,045 |
| Carvedilol ErCarvedilol Phosphate | 13 | $3,766 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $633 | $435,077391 claims |
| Johnson & JohnsonXarelto | $283 | $100,45273 claims |
| NovartisEntresto | $2,250 | $97,63682 claims |
| Boehringer IngelheimJardiance | $377 | $56,68961 claims |
| AstraZenecaFarxiga, Brilinta | $918 | $36,03928 claims |
| Axsome Therapeutics, Inc.Sunosi | $340 | $13,40216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Columbia
- Eric ShoupColumbia$74K
- Sydney MorrisColumbia$11K
- Janelle HinsonColumbia$11K
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.